Teriflunomide (Generic for Aubagio)

Introducing Teriflunomide formulated as per the Aubagio standard—an immunomodulatory agent that inhibits pyrimidine synthesis to reduce lymphocyte proliferation. This targeted tablet therapy decreases disease activity and relapse frequency while preserving neurological function, resulting in improved inflammatory control, enhanced cognitive stability, and superior quality of life for multiple sclerosis management.